← Back to Search

Behavioral Intervention

In-person treatment for Autism Spectrum Disorder

Phase 2 & 3
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child is aged 3 to 5 years inclusive
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 week intervals
Awards & highlights

Study Summary

This trial is aiming to find out if behavior therapy, which helps children with autism spectrum disorder (ASD) manage difficult behaviors, can be just as effective when done through telehealth (online) as

Who is the study for?
This trial is for children aged 3 to 5 with Autism Spectrum Disorder (ASD) who show challenging behavior daily. It's also for their English-speaking parents or caregivers, who can manage these behaviors safely and commit to a 12-week treatment program.Check my eligibility
What is being tested?
The study is testing if parent-mediated behavior therapy for kids with ASD can work just as well over telehealth as it does in person. Parents will be trained to help manage their child's challenging behaviors.See study design
What are the potential side effects?
Since this trial involves behavioral therapy and psychoeducation, there are no direct medical side effects like you'd expect from medication. However, stress or emotional discomfort may occur during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 3 and 5 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~previous 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and previous 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of challenging behavior
Parenting Stress Index

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: In-person treatmentActive Control1 Intervention
Group II: Telehealth-enabled treatmentActive Control1 Intervention
Group III: PsychoeducationPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
865 Previous Clinical Trials
327,609 Total Patients Enrolled
18 Trials studying Autism Spectrum Disorder
1,650 Patients Enrolled for Autism Spectrum Disorder
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,260 Total Patients Enrolled
33 Trials studying Autism Spectrum Disorder
4,007 Patients Enrolled for Autism Spectrum Disorder
Behavior Change InstituteUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently enrolling participants for this study?

"According to the available data on clinicaltrials.gov, this study is actively seeking participants. The trial was initially posted on January 1st, 2024 and has been recently updated as of the same date."

Answered by AI

Are individuals above the age of 20 eligible to participate in this study?

"For this investigation, participants between the ages of 3 and 5 years old are being sought for recruitment."

Answered by AI

What is the current number of participants being recruited for this clinical study?

"Indeed, the information available on clinicaltrials.gov confirms that this specific clinical trial is presently seeking participants. The trial was initially posted on January 1st, 2024 and has since been updated as of the same date. For this study, a total of 90 patients will be recruited from two distinct locations."

Answered by AI

Do I meet the criteria to participate in this medical research study?

"To be eligible for enrollment in this research study, individuals must have a diagnosis of autism spectrum disorder and fall within the age range of 3 to 5 years. The study has capacity to admit a total of 90 participants."

Answered by AI
~60 spots leftby Jun 2026